NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE
申请人:Yeda Research and Development Co. Ltd.
公开号:US20170273917A1
公开(公告)日:2017-09-28
The present invention provides pharmaceutical compositions comprising at least one NMDA receptor antagonist for use in treating neuropathic forms of Gaucher Disease (nGD).